Chace Franks, an Owensboro-based TikTok creator and nurse practitioner for nearly 10 years, recently gained national recognition after being featured in The New York Times.
A New York Times reporter reached out to Franks after seeing his content on GLP1, health, and weight loss topics on TikTok. He grew his audience to 116,000 followers in about a year and Franks’ presence was discovered through his informative content on Ozempic, catching the eye of publications such as Fortune magazine prior to this feature.
“Representing Owensboro on a national level — I feel honored and privileged to be able to represent the town,” he said. “It has been a cool ride so far and I’m just getting started.”
The recent article focused on the underrepresentation of men in the usage of GLP1 medication, a topic close to Franks’ heart as a GLP1 provider and patient. He currently works full-time as a provider for a telehealth company that provides the compound semaglutide.
Franks’ content delves into various aspects of male GLP1 use, including accessibility, dispelling misinformation, and advocating for its role in treating chronic obesity.
Through his TikTok handle @BourbonRx, Franks takes a relatable approach to educating his audience, steering clear of medical jargon and opting for straightforward explanations. His content addresses common questions and challenges stigmas surrounding obesity treatment with GLP1s.
As for the future. Franks said the goal is to continue to grow his social media following, but ultimately to educate and advocate for the most up-to-date treatment for obesity.
“I want to continue to raise awareness for these life-changing treatments and to reduce the stigma attached to GLP1 treatment,” he said. “I want to make people realize that obesity is a very complex, chronic endocrine disorder usually linked to hormonal imbalances and that it deserves chronic treatment just like other chronic illnesses.”
